ENTRY       D03203                      Drug
NAME        Abatacept (USAN/INN);
            Abatacept (genetical recombination) (JAN);
            Orencia (TN)
PRODUCT     ORENCIA (E.R. Squibb & Sons)
SEQUENCE    MGVLLTQRTL LSLVLALLFP SMASMAMHVA QPAVVLASSR GIASFVCEYA SPGKATEVRV
            TVLRQADSQV TEVCAATYMM GNELTFLDDS ICTGTSSGNQ VNLTIQGLRA MDTGLYICKV
            ELMYPPPYYL GIGNGTQIYV IDPEPCPDSD QEPKSSDKTH TSPPSPAPEL LGGSSVFLFP
            PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS
            VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS RDELTKNQVS
            LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS
            CSVMHEALHN HYTQKSLSLS PGK (Dimer: 146)
  TYPE      Peptide
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
REMARK      Therapeutic category: 3999
            ATC code: L04AA24
            Product: D03203<JP/US>
EFFICACY    Antirheumatic
  DISEASE   Rheumatoid arthritis [DS:H00630]
            Juvenile idiopathic arthritis [DS:H01672]
            Psoriatic arthritis [DS:H01507]
            Acute graft versus host disease [DS:H00084]
COMMENT     Abatacept is a fusion protein composed of an immunoglobulin fused to the extracellular domain of CTLA-4.
            Abatacept binds to CD80/86, to inhibit the CD28 costimulatory signal.
            Treatment of autoimmune diseases such as rheumatoid arthritis (selective co-stimulation modulator, binds to the B7 family of molecules expressed on antigen-presenting cells (APC))
TARGET      CD80 [HSA:941] [KO:K05412]
            CD86 [HSA:942] [KO:K05413]
  PATHWAY   hsa04514(941+942)  Cell adhesion molecules
            hsa04672(941+942)  Intestinal immune network for IgA production
            hsa05323(941+942)  Rheumatoid arthritis
INTERACTION  
STR_MAP     map07050  Antirheumatics - DMARDs and biological agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AA Selective immunosuppressants
                 L04AA24 Abatacept
                  D03203  Abatacept (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunological Agents, Other
               Selective T-cell costimulation modulators
                Abatacept
                 D03203  Abatacept (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D03203  Abatacept (USAN/INN); Abatacept (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               D03203  Abatacept
            Drug classes [BR:br08332]
             Antirheumatic agent
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               D03203  Abatacept
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD80
                 D03203  Abatacept (USAN/INN) &lt;JP/US&gt;
                CD86
                 D03203  Abatacept (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03203
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03203
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03203
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03203
DBLINKS     CAS: 332348-12-6
            PubChem: 17397357
///
